Aetion and Quinten Health partner to use AI and RWE to reduce research timelines
Aetion and Quinten Health have partnered up to better provide a range of real-world evidence (RWE) generation products and services by reducing complexity, increasing efficiency, and supporting rapid turnaround times to improve patient outcomes.
Aetion Co-Founder and President Jeremy Rassen said the partnership will allow for better utilization of the massive amounts of healthcare data hospitals produce each year—only three percent of which is currently used for research.
“Together, Quinten Health and Aetion are enabling researchers, clinicians, and regulators to derive greater value from health care data, offering a contextualized view of all the patients and populations that use or could potentially benefit from the studied therapies,” said Rassen. “We are proud to partner with Quinten Health, a pioneer of real-world health data science for precision medicine.”
The partnership will allow Aetion to integrate the Aetion Evidence Platform® (AEP) with Quinten Health’s extensive analytics and machine learning technologies. Quinten customers will then be able to generate hypotheses in its software—and then validate those using AEP.
To learn more about Aetion and Quinten’s new partnership, read the press release here.